4/A//SEC Filing
Stone Christopher Lewis 4/A
Accession 0000882104-19-000040
CIK 0000882104other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 5:17 PM ET
Size
6.2 KB
Accession
0000882104-19-000040
Insider Transaction Report
Form 4/AAmended
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Stock Option (right to buy)
2019-03-28+833,333→ 833,333 totalExercise: $3.72Exp: 2029-03-28→ Common stock (833,333 underlying)
Footnotes (2)
- [F1]The number of shares included in the original April 1, 2019 Form 4 filing was incorrect and the Company is filing this amendment to correct the number of shares in the award grant.
- [F2]The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on the one year anniversary of January 1, 2019 and (b) 75% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following the one year anniversary of January 1, 2019, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001453373
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 5:17 PM ET
- Size
- 6.2 KB